Managing Deviations with Confidence: Essential Insights into GDP Compliance

Confidence in GDP Deviation Control

Ensuring adherence to Good Distribution Practice (GDP) is fundamental to maintaining product quality, legal compliance, and, ultimately, patient safety.

When everyday activities on a licensed distribution site become complacent or shortcuts occur, the company can rapidly drift into a non-compliant state, often without immediate realisation.

Non-conformances and deviations are not peripheral paperwork issues. They are signals of departures from established regulatory standards, internal procedures or both, and must be investigated and corrected with measures taken to prevent recurrence.

The EU Guidelines on Good Distribution Practice (2013/C 343/01) make this explicit:

1.2 (v) “deviations from established procedures are documented and investigated; (vi) appropriate corrective and preventive actions (commonly known as ‘CAPA’) are taken to correct deviations and prevent them in line with the principles of quality risk management.”

The MHRA Green Guide, the UK’s authoritative reference for pharmaceutical distributors, similarly reinforces that departures from approved procedures cannot be ignored. The current 2022 edition consolidates EU GDP expectations and UK guidance, providing practical detail on how deviations and non-conformances should be managed within a compliant quality management framework.

The Reality of Small Deviations and the Risk of Complacency

It is a human tendency, especially in busy environments, to push aside what appears minor:

• • “It’s just a small paperwork error.”
  • “Someone else will catch this later.”
  • “We’ll sort it out next time we update the SOP.”

However, such thinking undermines the core principles of a robust Quality Management System (QMS).
A core soft skill of a Responsible Person is their ability to prioritise, and while this is important, this can lead to long closure times on deviations that are considered ‘smaller’, or near misses, to the overall risk of the business. This lack of oversight should be addressed as a deviation, to establish if the root cause of these deviations remaining open is a resource issue, unsuitable or overly complicated processes within the QMS that fill the time of the Quality Team, or something else altogether.

Leaving deviations undocumented or untreated does not make them disappear. Instead, it weakens your controlled environment and creates systemic vulnerabilities.

What the EU GDP Guidelines Expect

Consistency in quality is not optional under GDP. Chapter 1 of the EU GDP Guidelines states that wholesale distributors must maintain a comprehensive quality system setting out responsibilities, processes, and risk management principles for distribution activities.

Key aspects include:

• • Senior management, particularly the Licence Holder, must have active participation in maintaining oversight of the QMS
  • The Responsible Person must ensure the QMS is established, maintained and operational
  • Documentation of processes and deviations from normal practice
  • Quality risk management used to evaluate the impact of deviations and justify controls or improvements
  • Procedures for identifying, documenting, investigating, and closing deviations with clear timelines and responsibilities

These guidelines emphasise that every deviation must be evaluated, even if, after investigation, it is concluded that no deviation actually occurred. The investigation documentation must be retained and available for inspection.

This prevents a culture where “no deviation = no action,” which erases evidence of due diligence, restricts the identification of opportunities for improvement, and puts compliance at risk.

Consequences of Overlooking Deviations: More Than Just a Stigma

Many organisations initially see deviations as administrative burdens, or as embarrassing incidents that do not represent the interests and impression the organisation wishes to reflect to regulators, industry peers, and the wider public. However, the consequences of unmanaged non-conformances escalate quickly:

Regulatory Action
Regulators train inspectors to look for patterns of poor deviation management. A cluster of undocumented or improperly investigated deviations can trigger deeper scrutiny and more severe compliance classifications.

Quality System Compromise
Every undocumented deviation weakens the overall QMS by eroding the trust in documented processes and procedures.

Product Quality Risks
Without investigation and risk assessment, deviations can mask systemic issues that could compromise product integrity.

Patient Safety
Ultimately, non-conformances can impact product quality, safety, and efficacy, undermining patient trust and public health. For Marketing Authorisation or Manufacturers “Specials” licence holders, this could lead to product recalls, creating a shortage of product to those that need it most.

Financial and Reputational Cost
The cost of remediation after non-compliance findings often far outweighs the resources that would have been used for proper deviation handling. As any organisation knows, reputational damage has many more long term consequences and has the potential to be irreparable. 

Common Consequences of Ignoring Minor Issues

 

• • Document inaccuracies that compromise traceability and audit trails
  • Improper handling of goods, including storage and transportation errors
  • Informal, undocumented procedures spreading across personnel
  • Undocumented processes being carried out
  • Ineffective tracking of stock movements across the distribution chain
  • Compromised Quality Management System integrity
  • Inadequate storage environments, especially for temperature-sensitive products
  • Greater exposure to falsified medicines entering the supply chain

These issues are not abstract risks; they are precisely the types of deficiencies that inspectors check against during regulatory audits.
If identified, they can be classified as “Other”, “Major” or even “Critical” deficiencies, depending on the severity of the impact on product quality and patient safety.

During an inspection, it is exceptionally difficult to justify undocumented workarounds or dismissed deviations. Regulators expect a documented rationale, investigation, root cause analysis and appropriate corrective and preventive actions (CAPA) for each deviation, no matter how small.
If in doubt, document, investigate and action!

Deviation Management: Planned vs. Unplanned

Not all deviations are accidental. Many planned changes (for example, trialling a new SOP to improve efficiency), should be managed through an approved change control process.

Whether planned or unplanned:

• • Documentation must exist prior to implementation for planned changes
  • Risk assessments must be completed and reviewed by relevant competent personnel
  • Training should accompany procedural changes to ensure staff understand the rationale and correct application
  • There should be an associated review date for the effectiveness of the planned change

The EU GDP Guidelines link quality risk management and deviations directly:

Chapter 1:  “(vi) Appropriate corrective and preventive actions (commonly known as ‘CAPA’) are taken to correct deviations and prevent them in line with the principles of quality risk management.”

This highlights that deviation management is not only about dealing with errors, it is also about controlled, evidence-based improvement.

Training Is Not Optional: It’s a Regulatory Expectation

Attempting to manage deviations without formal training and structured procedures is not only unwise, it is high risk and can lead to major consequences to your QMS and your compliance status.
Both the EU GDP Guidelines and the MHRA Green Guide emphasise that personnel responsible for deviation handling must be competent and trained.

GDP compliance demands proactive engagement:

• • Staff must know how to identify deviations
  • They must understand how to document investigations
  • They must be competent in conducting root cause analyses
  • They must know how to apply corrective and preventive actions

A well-trained team mitigates risk not by avoiding deviations, but by responding to them professionally, consistently, and transparently.

Why Effective Deviation Handling Matters: Protecting Products and Patients

At the centre of GDP compliance is a singular priority: patient safety. Properly following procedures and adhering to GDP requirements ensures that:

• • Medicinal products maintain their quality, safety, and integrity throughout distribution
  • Risks to supply chain operations and patient outcomes are systematically managed
  • The organisation can demonstrate compliance and readiness for inspection

Ignoring small issues may seem benign in the moment, but under GDP and within the Green Guide framework, every deviation matters.

Conclusion: Embed Rigour, Not Risk

Non-conformances are not minor issues to be set aside; they are indicators that your quality system is working when properly handled.

Ignoring them is not only non-compliant, but also exposes your organisation to regulatory sanctions, compromised product quality, and, most importantly, risks to patient welfare.

Regulatory expectations are clear:

• • Record, investigate, and analyse all deviations
  • Apply corrective actions and preventive measures proportionate to the risk.
  • Train personnel and maintain oversight through competent quality leadership.

Systemic compliance is not an aspirational phrase, it is the foundation of professional GDP operations and a core obligation enforced in both the EU GDP Guidelines (2013/C 343/01) and the MHRA Green Guide.

We Can Help

Paradigm Shift Consulting have a comprehensive training platform, which includes a course specifically for the Management of Non-Conformances and Deviations. The course is clearly laid out and cost-effective. New start-up businesses are encouraged to engage general GDP Awareness training at the outset. Successfully completing the course will produce a certificate that is valid evidence of training, and presentable to inspectors, valid for 12 months.

Everything that Paradigm Shift Consulting does, is designed to help you do your job correctly and in a way that is with GDP compliance.

We treat your business as though it were our own.

Get In Touch

If you or your staff do not have GDP certification for this topic, enrol on our Deviation Management training as soon as possible. If you’re just getting started, train your staff immediately, as you cannot have staff engage their tasks without initial certificated GDP training (EU GDP Guidelines 2013/C 343/01, Ch 2.4, para 1).

You can call us on 0330 133 0920 anytime between 9am and 5.30pm GMT for advice or contact us with your enquiry using our contact form.